Company Filing History:
Years Active: 2022-2025
Title: The Innovations of Matthew Raymond Smith
Introduction
Matthew Raymond Smith is an accomplished inventor based in Didcot, GB. He has made significant contributions to the field of medical science, particularly in the area of respiratory diseases. With a total of 2 patents to his name, Smith's work focuses on the modulation of calcium-activated chloride channels, which play a crucial role in various physiological processes.
Latest Patents
Smith's latest patents include innovative compounds that serve as positive modulators of the calcium-activated chloride channel (CaCC), specifically TMEM16A. These compounds are designed to treat diseases and conditions that are influenced by the modulation of TMEM16A, with a particular emphasis on respiratory diseases. The compounds are defined by a general formula (I), wherein specific variables are outlined to indicate their unique properties and applications.
Career Highlights
Throughout his career, Matthew Raymond Smith has been associated with Tmem16a Limited, where he continues to develop groundbreaking solutions for health-related challenges. His expertise in the field has positioned him as a key player in the research and development of therapeutic compounds.
Collaborations
Smith has collaborated with notable colleagues, including Stephen Collingwood and Clive McCarthy, to advance the research and application of his inventions. Their combined efforts have contributed to the progress in understanding and utilizing TMEM16A for therapeutic purposes.
Conclusion
Matthew Raymond Smith's innovative work in the field of respiratory disease treatment showcases his dedication to improving health outcomes through scientific research. His patents reflect a commitment to advancing medical science and providing solutions for complex health issues.